Presentation TCT 2012 TCT-33. Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The... Presenter: Vasim Farooq October 23, 2012
Presentation TCT 2012 Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step! Presenter: Juan Granada October 23, 2012
Presentation TCT 2012 Yes: The Quantitative Threshold Should Be Lowered! Presenter: Maurice Sarano October 23, 2012
Presentation TCT 2012 TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group... Presenter: Rasha Al-Lamee October 23, 2012
Presentation TCT 2012 TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry Presenter: Eric van Belle October 23, 2012
Presentation TCT 2012 Treatment of Acute Decompensated HF Presenter: Dennis McNamara October 23, 2012
Presentation TCT 2012 Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices Presenter: Juan Granada October 23, 2012
Presentation TCT 2012 First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve) Presenter: Stefan Verheye October 23, 2012
Presentation TCT 2012 Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain) Presenter: Issam Mikati October 23, 2012